| The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy GC Nguyen, CH Seow, C Maxwell, V Huang, Y Leung, J Jones, ... Gastroenterology 150 (3), 734-757. e1, 2016 | 490 | 2016 |
| Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort C Ma, RN Fedorak, GG Kaplan, LA Dieleman, SM Devlin, N Stern, ... Alimentary pharmacology & therapeutics 45 (9), 1232-1243, 2017 | 167 | 2017 |
| Long-term maintenance of clinical, endoscopic, and radiographic response to ustekinumab in moderate-to-severe Crohn's disease: real-world experience from a multicenter cohort study C Ma, RN Fedorak, GG Kaplan, LA Dieleman, SM Devlin, N Stern, ... Inflammatory bowel diseases 23 (5), 833-839, 2017 | 116 | 2017 |
| Distance management of inflammatory bowel disease: systematic review and meta-analysis VW Huang, KM Reich, RN Fedorak World journal of gastroenterology: WJG 20 (3), 829, 2014 | 91 | 2014 |
| a decision‐making algorithm for the management of pregnancy in the inflammatory bowel disease patient FM Habal, VW Huang Alimentary pharmacology & therapeutics 35 (5), 501-515, 2012 | 79 | 2012 |
| CD71+ erythroid suppressor cells promote fetomaternal tolerance through arginase-2 and PDL-1 C Delyea, N Bozorgmehr, P Koleva, G Dunsmore, S Shahbaz, V Huang, ... The Journal of Immunology 200 (12), 4044-4058, 2018 | 73 | 2018 |
| Long-term efficacy and safety of ozanimod in moderately to severely active ulcerative colitis: results from the open-label extension of the randomized, phase 2 TOUCHSTONE study WJ Sandborn, BG Feagan, S Hanauer, S Vermeire, S Ghosh, WJ Liu, ... Journal of Crohn's and Colitis 15 (7), 1120-1129, 2021 | 72 | 2021 |
| Anti-TNF therapy within 2 years of Crohn's disease diagnosis improves patient outcomes: a retrospective cohort study C Ma, CL Beilman, VW Huang, DK Fedorak, KI Kroeker, LA Dieleman, ... Inflammatory bowel diseases 22 (4), 870-879, 2016 | 70 | 2016 |
| Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease C Ma, V Huang, DK Fedorak, KI Kroeker, LA Dieleman, BP Halloran, ... Alimentary pharmacology & therapeutics 40 (9), 1044-1055, 2014 | 58 | 2014 |
| The profile of human milk metabolome, cytokines, and antibodies in inflammatory bowel diseases versus healthy mothers, and potential impact on the newborn X Meng, G Dunsmore, P Koleva, Y Elloumi, RY Wu, RT Sutton, ... Journal of Crohn's and Colitis 13 (4), 431-441, 2019 | 56 | 2019 |
| Outpatient ulcerative colitis primary anti-TNF responders receiving adalimumab or infliximab maintenance therapy have similar rates of secondary loss of response C Ma, V Huang, DK Fedorak, KI Kroeker, LA Dieleman, BP Halloran, ... Journal of clinical gastroenterology 49 (8), 675-682, 2015 | 56 | 2015 |
| Systematic review with meta‐analysis: risk of adverse pregnancy‐related outcomes in inflammatory bowel disease P Tandon, V Govardhanam, K Leung, C Maxwell, V Huang Alimentary Pharmacology & Therapeutics 51 (3), 320-333, 2020 | 52 | 2020 |
| Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease? VW Huang, HJ Chang, KI Kroeker, KJ Goodman, KM Hegadoren, ... Canadian Journal of Gastroenterology and Hepatology 29, 95-103, 2015 | 52 | 2015 |
| Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy G Dunsmore, P Koleva, N Ghobakhloo, R Sutton, L Ambrosio, X Meng, ... Journal of Crohn's and Colitis 13 (2), 230-244, 2019 | 50 | 2019 |
| Crohn’s disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort study C Ma, V Huang, DK Fedorak, KI Kroeker, LA Dieleman, BP Halloran, ... Journal of Crohn's and Colitis 8 (11), 1454-1463, 2014 | 49 | 2014 |
| Noninvasive fecal immunochemical testing and fecal calprotectin predict mucosal healing in inflammatory bowel disease: a prospective cohort study C Ma, R Lumb, EV Walker, RR Foshaug, TNT Dang, S Verma, VW Huang, ... Inflammatory bowel diseases 23 (9), 1643-1649, 2017 | 47 | 2017 |
| The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: a systematic review and meta-analysis YH Kim, B Pfaller, A Marson, HW Yim, V Huang, S Ito Medicine 98 (38), e17309, 2019 | 44 | 2019 |
| Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy: a systematic review P Tandon, K Leung, A Yusuf, VW Huang Journal of Clinical Gastroenterology 53 (8), 574-581, 2019 | 41 | 2019 |
| Patient awareness of extraintestinal manifestations of inflammatory bowel disease V Huang, R Mishra, R Thanabalan, GC Nguyen Journal of Crohn's and Colitis 7 (8), e318-e324, 2013 | 41 | 2013 |
| Knowledge of fecal calprotectin and infliximab trough levels alters clinical decision-making for IBD outpatients on maintenance infliximab therapy VW Huang, C Prosser, KI Kroeker, H Wang, C Shalapay, N Dhami, ... Inflammatory Bowel Diseases 21 (6), 1359-1367, 2015 | 39 | 2015 |
Karen MadsenProfessor at the University of AlbertaBestätigte E-Mail-Adresse bei ualberta.ca
